✦ LIBER ✦

VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

✍ Scribed by Julie E. Chang; Christopher Peterson; Sangbum Choi; Jens C. Eickhoff; KyungMann Kim; David T. Yang; Leslie A. Gilbert; Eric S. Rogers; Jae E. Werndli; Michael S. Huie; Thomas A. McFarland; Michael Volk; Jules Blank; Natalie S. Callander; Walter L. Longo; Brad S. Kahl

Book ID: 108677395
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 276 KB
Volume: 155
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08820.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab and CHOP Chemotherapy Plus GM-

Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study

✍ Julie E. Chang; Songwong Seo; Kyungmann M. Kim; Jae E. Werndli; Wayne A. Bottner 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 128 KB

The hyper-CVAD–rituximab chemotherapy pr

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

✍ D. S. Ritchie; J. F. Seymour; A. P. Grigg; A. W. Roberts; R. Hoyt; S. Thompson; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 113 KB

Brief-Duration Rituximab/Chemotherapy Fo

Brief-Duration Rituximab/Chemotherapy Followed by Maintenance Rituximab in Patients With Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

✍ John D. Hainsworth; Ian W. Flinn; David R. Spigel; Bobby L. Clark; Paula L. Grin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 131 KB